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and supported by, the phenotypic PCP
features of Frizzled/PCP core group
genes on one side and that of the Fat/
Dachsous system on the other. Flies
carrying mutations in Frizzled/PCP core
proteins exhibit defects in PCP
throughout the wing. In contrast, the
Fat/Dachsous system mainly affects
polarity in the proximal half of the wing,
as this area strongly depends on cellular
realignment and rotation during the
switch to the proximal-distal PCP axis.
Together, these observations provide an
exciting new framework for under-
standing the generation of PCP and its676 Cell 142, September 3, 2010 ª2010 Elserelation to new mechanisms that sculpt
the shape of organs in general.
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In a tour-de-force study, Kobayashi et al. (2010) describe the first viable rat-mouse chimeras and
demonstrate that rat induced pluripotent stem (iPS) cells can rescue organ deficiency in mice.
Rat iPS cells formed a fully functional pancreas when injected into mouse blastocysts lacking the
Pdx1 gene required for pancreas formation.Experimentally produced chimeras
between different mouse strains (Tarkow-
ski, 1961) have been an exceedingly
useful tool for developmental biologists,
contributing to our understanding of the
establishment of cell lineages, cell deter-
mination, and the development of the
immune system and other organs. In this
issue of Cell, Kobayashi et al. (2010)
dramatically extend the potential of mam-
malian chimeras with their report of viable
rat-mouse chimeras that can develop to
term and become fully functional adults.
In their study, Kobayashi and col-
leagues relied on previous knowledge
but also added a few new wrinkles. They
first derived mouse and rat embryonic
stem (ES) cells and induced pluripotent
stem (iPS) cells using standard methodsfor the mouse and capitalizing on the
recent isolation of rat ES and iPS cells
(Buehr et al., 2008; Li et al., 2008). Both
mouse and rat cells were tagged with
different fluorescent dyes, allowing the
authors to follow their distribution in the
developing chimeras. The authors wanted
to prove, at least in principle, that xenoge-
neic organ complementation could be
achieved, that is, that donor cells of one
species could rescue a defect in organ
development in a recipient of a different
species. So, as a first step, they set out
to produce viable chimeras between rats
and mice, even though many previous
efforts to make such chimeras had failed.
The only viable intergeneric chimera—
that is, a hybrid between animals from
different genera—reported so far isthe geep between a sheep (Ovis aries)
and a goat (Capra hircus) (Fehilly et al.,
1984).
To test the possibility that viable rat-
mouse chimeras could be formed,
Kobayashi et al. (2010) injected fluores-
cently labeled mouse or rat iPS cells into
rat or mouse blastocysts, respectively,
and returned them to blastocyst-compat-
ible pseudopregnant females (that is,
foster mothers of the same species as
the blastocysts). The authors then exam-
ined the resulting fetuses, newborns, and
adults and found evidence of a substantial
contribution of donor stem cells to tis-
sues and organs of the host (Figure 1A).
Despite a big contribution of donor cells,
the size of newborn and adult chimeras
(with one exception) was determined by
Figure 1. Generating Rat-Mouse Chimeras
(A) Induced pluripotent stem (iPS) cells were derived from adult mouse and rat cells and were labeled with different fluorescent proteins. Rat (blue) and mouse
(red) iPS cells were injected into reciprocal blastocysts (mouse into rat and vice versa) to produce intergeneric chimeras. From these blastocysts, several
chimeras were born and some survived to adulthood. The contribution of injected donor stem cells was observed throughout the body of the host. The size
and morphology of the newborn and adult chimeras was determined by the host blastocyst.
(B) Fluorescently labeled rat iPS cells (blue) were injected into normal mouse blastocysts (left) or blastocysts lacking the Pdx1 gene (right), which encodes the
transcription factor pancreatic and duodenal homeobox 1 that is required for pancreas development. Chimeras derived from normal or Pdx1-deficient mouse
blastocysts showed an extensive contribution of rat cells to all tissues. However, in the Pdx1-deficient chimeras, the entire pancreas was derived from donor
rat cells (inset, blue) and was fully functional, including production of insulin by b islet cells.the species of the host blastocyst. It is not
clear whether it is the embryo itself or the
uterine environment that determines the
extent of chimera growth. To distinguish
between these possibilities, one would
have to transfer chimeric embryos into
the uterus of pseudopregnant females of
the same species as the donor stem cells
(not the blastocysts). Previous studies
suggest that such experiments would fail
because of the need for compatibility
between the fetal part of the placenta and
the uterus (Rossant et al., 1982).
Besides controlling the size and growth
of the chimera, the host blastocyst seems
to impose additional morphogenetic reg-
ulation. The postimplantation develop-
ment of normal rat and mouse embryos
is very similar, but there are differences
in organ morphogenesis. One of the
most noticeable differences is the pres-
ence of a gall bladder in mice and its
absence in rats. In all adult chimerasproduced by combining rat stem cells
and mouse blastocysts, the resulting
‘‘mouse-like’’ chimeras had a gall bladder
despite the significant contribution of rat
cells to abdominal organs. Reciprocal
chimeras were ‘‘rat-like’’ and, again,
despite a significant contribution from
mouse cells to abdominal organs, the
gall bladder was absent. These results
suggest that cells of the blastocyst inner
cell mass possess a ‘‘morphogenetic’’
capacity that controls the behavior of
injected stem cells at all developmental
stages.
This may explain why Kobayashi et al.
were able to successfully inject rat stem
cells into mouse blastocysts, whereas
insertion of the rat inner cell mass into
the mouse blastocyst cavity did not result
in viable rat-mouse chimeras (Gardner
and Johnson, 1973). This notion could
be tested further using tetraploid comple-
mentation (that is, donor ES or iPS cellsCell 142, Sare injected into tetraploid blastocysts)
to produce rat-mouse chimeras (Nagy
et al., 1993). Tetraploid blastocyst cells
cannot participate in formation of the
embryo proper; thus, the resulting fetus
(and adult) is derived entirely from the
injected cells, whereas the placenta and
extraembryonic membranes are derived
from the tetraploid blastocyst. It remains
to be seen whether this approach could
produce a fetus derived entirely from
mouse ES cells after their injection into
a rat tetraploid blastocyst that then
develops in the uterus of a pseudopreg-
nant rat female.
A major goal of the Kobayashi et al.
studywas to determinewhether stemcells
from a xenogeneic donor mammal could
correct a genetic defect in a recipient
mammal of a different species. So, in their
next set of experiments, the authors in-
jected rat iPS cells into recipient mouse
blastocysts that lacked the Pdx1 gene,eptember 3, 2010 ª2010 Elsevier Inc. 677
which encodes a transcription factor
(pancreatic and duodenal homeobox 1)
that is essential for development of the
pancreas and formation of insulin-
producing b islet cells. Although they
observed a substantial contribution of rat
cells to different organs and tissues, most
importantly, thepancreasof the rat-mouse
chimeraswas composed exclusively of rat
cells (Figure 1B). Thus, cells derived from
rat iPS cells were able to completely
rescue the genetic deficiency of the host
mouse blastocyst. These rat-mouse
chimeras developed into adult animals
withanormal functional pancreas,demon-
strating that xenogeneic organ comple-
mentation is achievable. This is a remark-
able accomplishment.
Sowhere dowe go fromhere? Although
human ES and iPS cells offer hope for
tissue and cell replacement therapies in
the not too distant future, the replacement
of complex organs—lung, kidney, liver,
gut, and, of course, pancreas—is likely to
be much more difficult. Several strategies
for organ replacement are being tested.
These include the growth of organs
in vitrowithmixtures of different stemcells
and biocompatible scaffolds or the gener-
ation of ‘‘humanized’’ pigs engineered to
lack certain antigens so that their organs
can be used for transplantation in human
patientswith a reduced chanceof immune
rejection. Could production of human
organs in, for example, human-pig
chimeras be an alternative approach?
Although production of viable rat-mouse
chimeras could be viewed as a first step
in this direction, as Kobayashi et al.
propose, there are huge biological and678 Cell 142, September 3, 2010 ª2010 Elsetechnical challenges. For example, the
mouse and rat are developmentally very
similar (apart from size), but it is not clear
that chimeras between animals belonging
to different phylogenetic families or orders
would be viable. Indeed, the only attempts
tomake such chimeras (between amouse
and a bank vole) have failed (Mystkowska,
1975). In this experiment, themouse-bank
vole chimeras were made by aggregation
of embryos; it is possible that injection of
bank vole stem cells into mouse blasto-
cysts, followed by their development
in the uterus of mouse foster mothers
might yield positive results. Successful
chimerism between members of different
orders (the pig and human, for example)
seems very unlikely, and attempts to
produce early postimplantation human-
mouse chimeras have not been encour-
aging (James et al., 2006). Even if we
succeed in developing organ-deficient
pigs by genetic manipulation and pro-
ducing pig-human chimeras in which the
parenchymal cells of the specific organ
are entirely derived from human cells,
immune rejection will still be a problem
because the human organ carried by the
pig will contain pig-derived stromal cells
and blood vessels.
Finally, there are huge legal and ethi-
cal barriers to creating human-animal
chimeras and, indeed, their production is
forbidden in most countries. However, it
is possible that injecting human ES or
iPS cells into a mouse blastocyst and al-
lowing limited (early postimplantation)
development of human-mouse chimeras
would be approved for the specific
purpose of testing the differentiationvier Inc.potential of human stem cells. Yet such
experiments will be complicated, time
consuming, difficult to interpret, and, I
suspect, will never become part of the
standard protocols regulating the medical
use of human stem cells. Although xeno-
geneic organ complementation is unlikely
to be a viable strategy for regenerative
medicine, the elegant work of Kobayashi
et al. is a boon for researchers seeking
to better understand the biology of stem
cells and mammalian development.REFERENCES
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